Answer
Somapacitan reaches steady-state exposure after 1–2 weekly administrations in adult and paediatric patients with growth hormone deficiency.
Sources for this answer
- Sogroya 10mg/1.5 mL solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked